Indication
Metastatic Castration-Resistant Prostate Cancer
The Metastatic Castration-Resistant Prostate Cancer pipeline: 2 tracked drugs.
Coverage in progress.The assets here come from their companies' published pipelines. AssetMemo has not yet run its full census of every drug in development for Metastatic Castration-Resistant Prostate Cancer, so this list is not complete.
1 Phase 21 preclinical / unstaged
Compare the share prices of listed companies in Metastatic Castration-Resistant Prostate Cancer →
Market size not yet sourced. How markets are sized ↗